Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.
Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians.
The full report is titled “Comparative Effectiveness of Sulfonylurea and Metformin Monotherapy on Cardiovascular Events in Type 2 Diabetes Mellitus. A Cohort Study.” It is in the 6 November 2012 issue of Annals of Internal Medicine (volume 157, pages 601-610). The authors are C.L. Roumie, A.M. Hung, R.A. Greevy, C.G. Grijalva, X. Liu, H.J. Murff, T.A. Elasy, and M.R. Griffin.
How Do Older Diabetes Drugs Compare in Their Effects on Heart and Blood Vessel Disease?. Ann Intern Med. 2012;157:I-28. doi: 10.7326/0003-4819-157-9-201211060-00001
Download citation file:
Published: Ann Intern Med. 2012;157(9):I-28.
Diabetes makes a person more likely to have a heart attack or stroke. Some newer diabetes drugs used to lower blood sugar levels have been shown to make heart attacks and strokes even more probable—as a result, these drugs have been taken off the market or restricted for use. This experience is a reminder that we know relatively little about the effects of older, commonly used diabetes drugs on heart attacks and strokes.
To compare the effects of older diabetes drugs on heart attacks and strokes.
More than 250,000 veterans with diabetes cared for in Veterans Health Administration hospitals throughout the United States.
The researchers identified all patients who were newly diagnosed with diabetes and who were starting therapy with 3 older, commonly used diabetes drugs: metformin, glyburide, or glipizide. They combined people using glyburide and glipizide because the 2 drugs are similar. The researchers determined how many people required hospitalization for heart attacks or strokes and how many died in the glyburide and glipizide group compared with the metformin group.
People using metformin were less likely to be hospitalized for a heart attack or stroke or to die than those taking glyburide or glipizide.
The findings suggest that metformin is more likely to prevent heart attacks, strokes, and death than glyburide and glipizide. But, because the researchers did not study people who were not taking any diabetes drugs, this study could not determine whether heart attacks, strokes, and death are more or less probable compared with no drug. Factors other than the drugs could have contributed to the differences in heart attacks, strokes, and deaths. However, the researchers did many analyses to find other factors but did not find any. Finally, most study participants were men, so the findings may not apply to women.
Metformin seems to be better at preventing heart attacks, strokes, and death than glyburide and glipizide and probably should be tried first by people who have a new diagnosis of diabetes and require drug treatment.
The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.
Cardiology, Endocrine and Metabolism, Diabetes, Coronary Risk Factors.
Results provided by:
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only